Brief: Sesen Bio, Carisma Therapeutics Announce Merger Agreement

Carisma Therapeutics

21/09/2022 13:46

Sept 21 (Reuters) - Sesen Bio Inc  SESN.O :
    * SESEN BIO AND CARISMA THERAPEUTICS ANNOUNCE MERGER
AGREEMENT
    * SESEN BIO INC - CASH RUNWAY OF COMBINED COMPANY EXPECTED
TO
ENABLE MULTIPLE CLINICAL READOUTS ACROSS CARISMA PROGRAMS
    * SESEN BIO INC - COMBINED COMPANY EXPECTED TO HAVE
APPROXIMATELY
$180 MILLION OF CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES
    * SESEN BIO INC - MERGER AND RELATED FINANCING ARE EXPECTED
TO
CLOSE IN NEXT THREE TO FOUR MONTHS

Source text for Eikon:  ID:nBw8HVTdla 
Further company coverage:  SESN.O 

 ((Reuters.Briefs@thomsonreuters.com;))